Unifying Continuous Biomanufacturing Operations
June 14, 2017 - BioPharm Intl.

The success of a truly integrated continuous processing platform relies on the collaborative efforts of upstream and downstream specialists.

Managing Residual Impurities During Downstream Processing
June 14, 2017 - BioPharm Intl.

Increased understanding of potential impurities has spurred efforts to standardize monitoring procedures.

By Cynthia A. Challener

Tips for Protein Purification Method Editing
May 31, 2017 - Cytiva

Protein purification questions and answers from ÄKTA club web chat.

The Extreme Costs of a Bioburden Incident
May 18, 2017 - Cytiva

The cost of bioburden incidents can vastly outweigh the costs of preventing them.

Protein Purification Questions and Answers from ÄKTA Club Web Ch


May 18, 2017 - Cytiva

Do you have recurring discussions in your lab that you need input

Fusion Proteins Pose Manufacturability Challenges
May 18, 2017 - BioPharm Intl.

The unique structures of fusion proteins lead to expression, heterogeneity, and stability issues.

By Cynthia A. Challener

Sources of Bioburden You Might Have Missed
May 4, 2017 - Cytiva

A problem with traditional mAb manufact

Witnessing Major Growth in Next-Generation Antibodies
May 4, 2017 - BioPharm Intl.

Including next-gen antibodies in pharma pipelines is considered essential for future success.

By Cynthia A. Challener

Being Thorough When Transferring Technology
May 4, 2017 - BioPharm Intl.

Communication and taking the time to develop the process are key to successful transfer and scale up of biologics.

By Susan Haigney

Improvements in Protein A Chromatography
May 4, 2017 - Process Development Forum

Process Development Forum speaks about Protein A chromatography with Glen Bolton, Scientific Director at Amgen. Bolton recently published a pap

Previous PageNext Page